Samrat Pharmachem Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Samrat Pharmachem Ltd. on BSE

Search Inside the pdf :

Samrat Pharmachem Ltd.

20 Mar 2025, 02:11PM

323.35

0.48%

SAST

Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading Window

BSE India

The trading window of the company shall remain closed from Tuesday, April 1, 2025 till 48 hours after the declaration of the Audited Financial Results of the company for the year ended March 31, 2025.

pdf

Samrat Pharmachem Ltd.

04 Mar 2025

323.35

0.48%

Corp. Note

SAMRAT PHARMACHEM LTD.-$ - 530125 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

323.35

0.48%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - General Announcement-Outcome Of Board Meeting (14-02-2025)

BSE India

Due to inadvertence, the start and end time of the Board Meeting held today was input in Indian time (02:00 to 03:30) instead of international time zone (14:00 to 15:30) during the filing of outcome of board meeting under corporate announcements. Correct Start & End time is: Start: 14:00 hrs End: 15:30 hrs

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

323.35

0.48%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Outcome Of The Board Meeting Held Today - 14-02-2024

BSE India

Due to inadvertence, the start & end time of Board meeting was input in Indian time (02:00 To 03:30) instead of international time zone (14:00 To 15:30). The correct date & time of board meeting is as under: Date of board meeting: 14-02-2025 Commencement time: 14:00 hrs End time: 15:30 hrs

pdf

Samrat Pharmachem Ltd.

14 Feb 2025

323.35

0.48%

Result

SAMRAT PHARMACHEM LTD.-$ - 530125 - Approval Of Un-Audited Financial Results For The Quarter Ended December …

BSE India

Approval of UFR 31-12-2024

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	63.67	70.66	62.09	-9.9%	2.5%
Operating Profit Qtr	4.17	3.36	0.11	24.1%	3690.9%
Net Profit Qtr	2.78	2.66	0.34	4.5%	717.6%
Earning Per Share Adjusted latest Qtr	9.01	8.61	1.11	4.6%	711.7%

* Standalone data

Detailed Results

Samrat Pharmachem Ltd.

14 Feb 2025

323.35

0.48%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

BSE India

The Board has considered and took on record the Un-audited Financial Results for the quarter ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

13 Jan 2025

323.35

0.48%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate u/r 74(5) of SEBI (DP), Reg 2018 for the quarter ended December 31, 2024

pdf

Samrat Pharmachem Ltd.

13 Jan 2025

323.35

0.48%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in RTA

BSE India

The name of our RTA has changed from Link Intime India Private Limited to MUFG Intime India Private Limited effective from December 31, 2024.

pdf

Samrat Pharmachem Ltd.

31 Dec 2024

323.35

0.48%

SAST

SAMRAT PHARMACHEM LTD.-$ - 530125 - Closure of Trading Window

BSE India

The Trading Window of the company shall remain closed from Wednesday, January 1, 2025 till 48 hours after the declaration of Un-audited financial results of the company for the quarter ended December 31, 2024.

pdf

Samrat Pharmachem Ltd.

31 Dec 2024

323.35

0.48%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter …

BSE India

SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the Un-audited financial results of the company for the quarter ended December 31, 2024

pdf

No results found

Is Samrat Pharmachem Ltd. worth buying?

44 Votes:

Buy 68.18%

Sell 13.64%

Hold 18.18%